Industry: Pharmaceuticals, Biotechnology
Mersana, a privately-held, venture-backed company, is focused on developing novel oncology agents based on the breakthrough discovery of Dr. Mikhail Papisov of Massachusetts General Hospital, who devised a ‘stealth’ material called Fleximer® that enhances the pharmacokinetics and safety of drugs. Mersana, formerly Nanopharma Corp., was co-founded by Dr. Papisov and PureTech Ventures, a life science venture creation fund. The Fleximer patents and six related patent families are licensed from the Massachusetts General Hospital. Mersana’s pipeline includes compounds with activity against multiple tumor types and human proof-of-concept that are improved by its proprietary technologies. ( www.mersana.com )
Mersana Therapeutics , Inc.
840 Memorial Drive
Cambridge, Massachusetts 02139
USA
Tel: (617) 498-0020
Fax: (617) 498-0109